Improving Clinical and Commercial stage clients in commercial launch and business process development and delivery for supply and demand planning, artwork, packaging and labeling, CMO governance, cold-chain logistics, distribution, warehousing, 3PLs, material management, serialization, global trade compliance, order fulfillment, and customer service.

A microbiome pharmaceutical company developing treatments for serious diseases via healing capabilities in gut bacteria.
● Senior Director, Global Supply Chain (10/2021 – 11/2023) Reporting to the vice president, operations, and supply chain, with the primary accountability to develop, deploy and lead the first end-2-end commercial supply chain team. Responsible for developing and delivering accelerated launches of new products serving patients and meeting enterprise growth ambitions.
• Global leader for sales and operations planning (S&OP), logistics and distribution, supply chain procurement and sourcing, supply planning and demand management (internal and external manufacturing), inventory strategy and management, trade compliance, and commercial artwork and packaging reducing operational costs by $2M after first year of operation.
• Prepared the global supply chain for FDA pre-approval inspection (PAI) in support of GMP and good distribution practices (GDP) review.
• Drove the

Reporting to the vice president of global supply chain was accountable for the development and successful development and delivery of global internal and external supply chains supporting new product introductions, expanded access programs, network changes, site integrations, and separations due to mergers and acquisitions. Developed and delivered strategy and operations for each supply chain node ensuring successful product launch and new business activity from R&D phase 2 to the first commercial sale.
• Delivered over +30 end to end supply chain launches for new product introductions, new contract manufacturing organizations, cell and gene therapy, biopharmaceuticals, and expanded access programs on time.
• Drove performance management processes to reduce risk to the operations supply chain change programs.
• Introduced the launch acceleration and scenario planning service to streamline approval to launch timelines.

Reporting to the vice president of global supply chain and was accountable for integrating business growth due to the new R&D product pipeline; on-boarding contract management organizations, mergers, and acquisitions; and in licensing to the supply chain.
• Delivered over 20 launches of new products in the supply chain globally, supporting over $2B in sales growth.
• Reduced the number of delayed or late product launches due to distribution issues by 100% year over year.
• Delivered 5 supply chain business merger/acquisitions and 3 product line divestments, and while ensuring 100% successful project timelines.
• Delivered "site to market" transport and cross-border strategies along with new business development for contract manufacturing organizations, pharma, consumer healthcare, biopharmaceuticals, and biologics businesses.

Reporting to the executive director of global distribution and warehousing. This role was accountable for operational and strategic leadership of 3PL global logistics, warehousing, and domestic and international distribution processes for the Americas. Responsible for global relationships and service delivery by third-party logistics service providers (LSPs). Led the global distribution analytics team.
• Delivered over $2M in savings in the first 12 months of operation following the successful implementation of the logistics service provider strategy in North America.
• Delivered logistics projects, resulting in $10M of total cost savings over five years.
• Reduced duty spend by $4M annually by proper use of harmonized tariffs and free trade agreements.
• Improved the US Customs and Border Patrol import data compliance rating from 89% to 100%.
• Drove C-TPAT and TSA Certified Cargo Screening into the business, improving the cross-border product flow.